Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915002008> ?p ?o ?g. }
- W2915002008 endingPage "2046" @default.
- W2915002008 startingPage "2035" @default.
- W2915002008 abstract "In Japan, bezafibrate (BF) is a second‐line agent for primary biliary cholangitis (PBC) that is refractory to ursodeoxycholic acid (UDCA) treatment. From a retrospective cohort (n = 873) from the Japan PBC Study Group, we enrolled 118 patients who had received UDCA monotherapy for at least 1 year followed by combination therapy with UDCA+BF for at least 1 year. GLOBE and UK‐PBC scores after UDCA monotherapy (i.e., immediately before UDCA+BF combination therapy) were compared with those after 1 year of UDCA+BF combination therapy. The real outcomes of enrolled patients estimated by Kaplan–Meier analysis were compared with the predicted outcomes calculated using GLOBE and UK‐PBC scores. In addition, the hazard ratio of BF treatment was calculated using propensity score analysis. The mean GLOBE score before the combination therapy was 0.504 ± 0.080, which improved significantly to 0.115 ± 0.085 ( P < 0.0001) after 1 year of combination therapy. The real liver transplant‐free survival of enrolled patients was significantly better than that predicted by GLOBE score before introducing BF. Combination therapy did not significantly improve the real rates of liver transplantation or liver‐related death compared with those predicted by UK‐PBC risk score before introducing BF, but the predicted risk was significantly reduced by the addition of BF ( P < 0.0001). Cox regression analysis with inverse probability of treatment weighting showed that the addition of BF significantly reduced the hazard of liver transplant or liver‐related death in patients who, after 1 year of UDCA monotherapy, had normal serum bilirubin (adjusted hazard ratio 0.09, 95% confidence interval 0.01‐0.60, P = 0.013). Conclusion: Addition of BF to UDCA monotherapy improves not only GLOBE and UK‐PBC scores but also the long‐term prognosis of PBC patients, especially those with early‐stage PBC." @default.
- W2915002008 created "2019-02-21" @default.
- W2915002008 creator A5000234436 @default.
- W2915002008 creator A5003339273 @default.
- W2915002008 creator A5010716671 @default.
- W2915002008 creator A5014820628 @default.
- W2915002008 creator A5017931660 @default.
- W2915002008 creator A5017999006 @default.
- W2915002008 creator A5023074362 @default.
- W2915002008 creator A5023553051 @default.
- W2915002008 creator A5024647870 @default.
- W2915002008 creator A5031398294 @default.
- W2915002008 creator A5036475624 @default.
- W2915002008 creator A5039741962 @default.
- W2915002008 creator A5039868198 @default.
- W2915002008 creator A5041744856 @default.
- W2915002008 creator A5041908000 @default.
- W2915002008 creator A5043674871 @default.
- W2915002008 creator A5047380294 @default.
- W2915002008 creator A5050334711 @default.
- W2915002008 creator A5055058397 @default.
- W2915002008 creator A5056188389 @default.
- W2915002008 creator A5057910360 @default.
- W2915002008 creator A5059237008 @default.
- W2915002008 creator A5065019765 @default.
- W2915002008 creator A5065371004 @default.
- W2915002008 creator A5069666690 @default.
- W2915002008 creator A5075913064 @default.
- W2915002008 creator A5075962830 @default.
- W2915002008 creator A5077398626 @default.
- W2915002008 creator A5080913502 @default.
- W2915002008 creator A5081361453 @default.
- W2915002008 creator A5084065201 @default.
- W2915002008 creator A5091416334 @default.
- W2915002008 date "2019-04-12" @default.
- W2915002008 modified "2023-10-12" @default.
- W2915002008 title "Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis" @default.
- W2915002008 cites W1071546559 @default.
- W2915002008 cites W136997036 @default.
- W2915002008 cites W1527121125 @default.
- W2915002008 cites W1532206343 @default.
- W2915002008 cites W1539564928 @default.
- W2915002008 cites W1559882044 @default.
- W2915002008 cites W1973298751 @default.
- W2915002008 cites W1974694649 @default.
- W2915002008 cites W1984620293 @default.
- W2915002008 cites W1990027295 @default.
- W2915002008 cites W1994968614 @default.
- W2915002008 cites W1995419534 @default.
- W2915002008 cites W2027862649 @default.
- W2915002008 cites W2028940189 @default.
- W2915002008 cites W2033362089 @default.
- W2915002008 cites W2045663338 @default.
- W2915002008 cites W2058865320 @default.
- W2915002008 cites W2063975050 @default.
- W2915002008 cites W2075115765 @default.
- W2915002008 cites W2076982518 @default.
- W2915002008 cites W2079345345 @default.
- W2915002008 cites W2085108629 @default.
- W2915002008 cites W2086263816 @default.
- W2915002008 cites W2090145657 @default.
- W2915002008 cites W2107746791 @default.
- W2915002008 cites W2109684648 @default.
- W2915002008 cites W2131379299 @default.
- W2915002008 cites W2135800699 @default.
- W2915002008 cites W2144168223 @default.
- W2915002008 cites W2153174384 @default.
- W2915002008 cites W2158609797 @default.
- W2915002008 cites W2161458396 @default.
- W2915002008 cites W2170684362 @default.
- W2915002008 cites W2316970164 @default.
- W2915002008 cites W2481743145 @default.
- W2915002008 cites W2518389324 @default.
- W2915002008 cites W2552097960 @default.
- W2915002008 cites W2575398213 @default.
- W2915002008 cites W2762689973 @default.
- W2915002008 cites W2786456523 @default.
- W2915002008 cites W2807617765 @default.
- W2915002008 cites W4295008070 @default.
- W2915002008 doi "https://doi.org/10.1002/hep.30552" @default.
- W2915002008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30737815" @default.
- W2915002008 hasPublicationYear "2019" @default.
- W2915002008 type Work @default.
- W2915002008 sameAs 2915002008 @default.
- W2915002008 citedByCount "77" @default.
- W2915002008 countsByYear W29150020082018 @default.
- W2915002008 countsByYear W29150020082019 @default.
- W2915002008 countsByYear W29150020082020 @default.
- W2915002008 countsByYear W29150020082021 @default.
- W2915002008 countsByYear W29150020082022 @default.
- W2915002008 countsByYear W29150020082023 @default.
- W2915002008 crossrefType "journal-article" @default.
- W2915002008 hasAuthorship W2915002008A5000234436 @default.
- W2915002008 hasAuthorship W2915002008A5003339273 @default.
- W2915002008 hasAuthorship W2915002008A5010716671 @default.
- W2915002008 hasAuthorship W2915002008A5014820628 @default.
- W2915002008 hasAuthorship W2915002008A5017931660 @default.
- W2915002008 hasAuthorship W2915002008A5017999006 @default.